Publication: Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide
Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide
Date
Date
Date
Citations
Polton, G., Finotello, R., Sabattini, S., Rossi, F., Laganga, P., Vasconi, M. E., Barbanera, A., Stiborova, K., Rohrer Bley, C., & Marconato, L. (2018). Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide. Veterinary and Comparative Oncology, 16(3), 399–408. https://doi.org/10.1111/vco.12393
Abstract
Abstract
Abstract
Unresectable or metastatic (advanced) primary pulmonary carcinoma (PPC) represents a therapeutic challenge where surgery may be contraindicated and the therapeutic role of maximum-tolerated dose (MTD) chemotherapy remains uncertain. This study was undertaken to explore the impact of metronomic chemotherapy (MC) in dogs with advanced PPC. Previously untreated dogs with advanced (T3 or N1 or M1) PPC, with complete staging work-up and follow-up data, receiving MC (comprising low-dose cyclophosphamide, piroxicam and thalidomide), surgery,
Additional indexing
Creators (Authors)
- Polton, G
- Finotello, R
- Sabattini, S
- Rossi, F
- Laganga, P
- Vasconi, M E
- Barbanera, A
- Stiborova, K
- Marconato, L
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Citations
Polton, G., Finotello, R., Sabattini, S., Rossi, F., Laganga, P., Vasconi, M. E., Barbanera, A., Stiborova, K., Rohrer Bley, C., & Marconato, L. (2018). Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide. Veterinary and Comparative Oncology, 16(3), 399–408. https://doi.org/10.1111/vco.12393
